Evidence map›Paper›PMID 29230365›Full record

ArticlePeerJ2017

Identification and characterization of a novel zebrafish (

Maarit S Patrikainen, Martti E E Tolvanen, Ashok Aspatwar, Harlan R Barker, Csaba Ortutay, Janne Jänis, Mikko Laitaoja, Vesa P Hytönen, Latifeh Azizi, Prajwol Manandhar and 6 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Maarit S Patrikainen *Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.ORCID 0000-0001-9698-278X
Martti E E Tolvanen *Department of Future Technologies, University of Turku, Turku, Finland.
Ashok Aspatwar *Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.ORCID 0000-0002-6938-7835
Harlan R BarkerFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Csaba OrtutayHiDucator Ltd., Kangasala, Finland.
Janne JänisDepartment of Chemistry, University of Eastern Finland, Joensuu, Finland.ORCID 0000-0002-8446-4704
Mikko LaitaojaDepartment of Chemistry, University of Eastern Finland, Joensuu, Finland.
Vesa P HytönenFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.ORCID 0000-0002-9357-1480
Latifeh AziziFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Prajwol ManandharFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Edit JágerDepartment of Epidemiology, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary.ORCID 0000-0003-2601-8391
Daniela VulloDipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Florence, Italy.
Sampo KukkurainenFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Mika HilvoFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.ORCID 0000-0003-0663-5843
Claudiu T SupuranDipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Florence, Italy.
Seppo ParkkilaFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.ORCID 0000-0001-7323-8536
Tampere University · FIUniversity of Eastern Finland · FIUniversity of Florence · ITSemmelweis University · HUUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarbonic anhydrases (CAs) are ubiquitous, essential enzymes which catalyze the conversion of carbon dioxide and water to bicarbonate and H

methodsWe isolated and sequenced zebrafish (

resultsThe recombinant enzyme has a very high carbonate dehydratase activity. Sequencing confirms a 530-residue protein identical to one of the predicted proteins in the Ensembl database (ensembl.org). The protein is pentameric in solution, as studied by gel filtration and light scattering, presumably joined by the PTX domains. Mass spectrometry confirms the predicted signal peptide cleavage and disulfides, and N-glycosylation in two of the four observed glycosylation motifs. Molecular modeling of the pentamer is consistent with the modifications observed in mass spectrometry. Phylogenetics and sequence analyses provide a consistent hypothesis of the evolutionary history of domains associated with CA VI in mammals and non-mammals. Briefly, the evidence suggests that ancestral CA VI was a transmembrane protein, the exon coding for the cytoplasmic domain was replaced by one coding for PTX domain, and finally, in the therian lineage, the PTX-coding exon was lost. We knocked down CA VI expression in zebrafish embryos with antisense morpholino oligonucleotides, resulting in phenotype features of decreased buoyancy and swim bladder deflation in 4 dpf larvae. DISCUSSION: These findings provide novel insights into the evolution, structure, and function of this unique CA form.

Indexed as

Carbonic anhydraseCarbonic anhydrase VIInnate immunityKnockdownMass spectrometryPentraxinPhylogenyProtein modelingZebrafish

Identifiers

PMID29230365
PMCPMC5723433
OpenAlexW2773941201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.